Summary
This prediction ended on 05.05.23 with a price of €4.61. The BUY prediction by BiotechBee for Altimmune performed very badly with a performance of -77.51%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Altimmune | -17.253% | -17.253% | -43.646% | -53.006% |
| iShares Core DAX® | -0,20 % | 5,47 % | 9,19 % | 48,66 % |
| iShares Nasdaq 100 | 2,57 % | 10,09 % | 39,29 % | 95,72 % |
| iShares Nikkei 225® | 0,60 % | 9,87 % | 46,20 % | 63,77 % |
| iShares S&P 500 | 1,80 % | 7,40 % | 29,62 % | 67,24 % |
According to BiotechBee what are the pros and cons of Altimmune for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Altimmune diskutieren
Buy mit Kursziel 38,0